YD Bio Ltd - *W EXP 08/28/203 (YDESW)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / *W EXP 08/28/203
Total 13F shares
4,960,719
Share change
+4,859,689
Total reported value
$10,565,536
Price per share
$2.13
Number of holders
9
Value change
+$10,350,341
Number of buys
8

Institutional Holders of YD Bio Ltd - *W EXP 08/28/203 (YDESW) as of Q3 2025

As of 30 Sep 2025, YD Bio Ltd - *W EXP 08/28/203 (YDESW) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,960,719 shares. The largest 9 holders included Cypress Capital Management LLC (WY), Cerity Partners LLC, True North Advisors, LLC, Clear Street Group Inc., Merit Financial Group, LLC, WOLVERINE ASSET MANAGEMENT LLC, Concurrent Investment Advisors, LLC, ARISTEIA CAPITAL, L.L.C., and BANK OF AMERICA CORP /DE/. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.